Express Pharma

AYUSH sector gets investment commitments of Rs 9,000 crores

The investments come across major categories like FMCG, Medical Value Travel (MVT) and services, pharma, agriculture, technology and diagnostics

1 233

The AYUSH Ministry last week said it has received Letters of Intent (LoI) from various companies committing to the investment of Rs 9,000 crores during the three-day Global AYUSH Investment and Innovation Summit (GAIIS) held.

The three-day summit, inaugurated by Prime Minister Narendra Modi on 20th April at Mahatma Mandir in Gandhinagar, came to an end on 22nd April with entrepreneurs submitting LoIs to the tune of Rs 9,000 crores for the sector, a release by the ministry said.

The investments come across major categories like FMCG, Medical Value Travel (MVT) and services, pharma, agriculture, technology and diagnostics.

During the summit, more than 70 memoranda of understanding (MoUs) were signed among countries, research institutes, farmers’ groups and industry.

The first GAIIS saw participation from more than 30 FMCG companies including Amul, Dabur, Kama Ayurveda, Accord, AyurVAID, Natural Remedies, Ambro Pharma and Patanjali.

The proposed investment in the AYUSH sector is expected to create around 5.5 lakh jobs, said the release.

In his address at the valedictory session of the summit, Sarbananda Sonowal, Union Minister, AYUSH, said the AYUSH sector is growing and achieving unprecedented milestones under the mentorship of PM Modi.

The summit, organised in line with Sustainable Development Goal Number 3 of promoting good health and well-being, witnessed the presence of 90 eminent speakers and 100 exhibitors, said the release.

Sonowal added the investors and the entrepreneurs of the world have realised the “comparative advantages which AYUSH is offering, and the AYUSH sector has unprecedentedly grown to more than $18 billion globally.”

Edits by EP News Bureau

- Advertisement -

1 Comment
  1. kamir bouchareb st says

    gooooooooooood

Leave A Reply

Your email address will not be published.